PL1796650T3 - Nanocząstki zawierające dostarczające podłoże - Google Patents

Nanocząstki zawierające dostarczające podłoże

Info

Publication number
PL1796650T3
PL1796650T3 PL05784613T PL05784613T PL1796650T3 PL 1796650 T3 PL1796650 T3 PL 1796650T3 PL 05784613 T PL05784613 T PL 05784613T PL 05784613 T PL05784613 T PL 05784613T PL 1796650 T3 PL1796650 T3 PL 1796650T3
Authority
PL
Poland
Prior art keywords
delivery vehicle
containing nanoparticles
vehicle containing
present
vehicles
Prior art date
Application number
PL05784613T
Other languages
English (en)
Inventor
Kerstin Ringe
Hans-Eckart Radunz
Katharina Landfester
Clemens Weiss
Original Assignee
Nanodel Tech Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04027997A external-priority patent/EP1661559A1/en
Application filed by Nanodel Tech Gmbh filed Critical Nanodel Tech Gmbh
Publication of PL1796650T3 publication Critical patent/PL1796650T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
PL05784613T 2004-09-14 2005-09-14 Nanocząstki zawierające dostarczające podłoże PL1796650T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04021855 2004-09-14
EP04027997A EP1661559A1 (en) 2004-11-25 2004-11-25 Delivery vehicle manufactured by the miniemulsion method
PCT/EP2005/009894 WO2006029845A2 (en) 2004-09-14 2005-09-14 Delivery vehicle containing nanoparticles
EP05784613A EP1796650B1 (en) 2004-09-14 2005-09-14 Delivery vehicle containing nanoparticles

Publications (1)

Publication Number Publication Date
PL1796650T3 true PL1796650T3 (pl) 2009-06-30

Family

ID=35788673

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05784613T PL1796650T3 (pl) 2004-09-14 2005-09-14 Nanocząstki zawierające dostarczające podłoże

Country Status (11)

Country Link
US (1) US20070292524A1 (pl)
EP (1) EP1796650B1 (pl)
JP (1) JP2008513363A (pl)
CN (1) CN101072553A (pl)
AT (1) ATE419842T1 (pl)
CA (1) CA2579957A1 (pl)
DE (1) DE602005012289D1 (pl)
DK (1) DK1796650T3 (pl)
ES (1) ES2318531T3 (pl)
PL (1) PL1796650T3 (pl)
WO (1) WO2006029845A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072710A2 (en) * 2004-01-28 2005-08-11 Johns Hopkins University Drugs and gene carrier particles that rapidly move through mucous barriers
EP1815851A1 (en) * 2006-02-03 2007-08-08 NanoDel Technologies GmbH Nanoparticles designed for drug delivery
EP1876188A1 (en) * 2006-07-04 2008-01-09 NanoDel Technologies GmbH Two step miniemulsion process
JP2010502713A (ja) * 2006-09-08 2010-01-28 ザ・ジョンズ・ホプキンス・ユニバーシティー 粘液を通る輸送を増強するための組成物および方法
US7984714B2 (en) * 2006-09-29 2011-07-26 Nellcor Puritan Bennett Llc Managing obstructive sleep apnea and/or snoring using local time released agents
US8512697B2 (en) * 2007-05-16 2013-08-20 The University Of North Carolina At Chapel Hill Delivery of micro- and nanoparticles with blood platelets
PE20091964A1 (es) 2008-05-06 2010-01-09 Glaxo Group Ltd Encapsulacion de agentes biologicamente activos
DK2563426T3 (en) 2010-04-30 2018-04-16 H R D Corp APPLICATION WITH HIGH DIFFERENTIAL SPEEDS IN MEDICAL THERAPY
US8888736B2 (en) 2010-04-30 2014-11-18 H R D Corporation High shear application in medical therapy
KR20130100290A (ko) 2010-08-30 2013-09-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 협착성 병변을 위한 전단 제어 방출 및 혈전 용해 치료법
DK2640426T3 (en) * 2010-11-16 2016-05-02 Selecta Biosciences Inc Immunostimulating Oligonucleotides
WO2013166408A1 (en) 2012-05-03 2013-11-07 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9056057B2 (en) 2012-05-03 2015-06-16 Kala Pharmaceuticals, Inc. Nanocrystals, compositions, and methods that aid particle transport in mucus
US10555911B2 (en) 2012-05-04 2020-02-11 Yale University Highly penetrative nanocarriers for treatment of CNS disease
GB201304245D0 (en) * 2013-03-08 2013-04-24 Inst Quimic De Sarria Chemical compounds
CN104231137A (zh) * 2014-10-10 2014-12-24 河北科技大学 一种聚合物包埋疏水性抗肿瘤药物纳米复合微球的制备方法
EP3217248B1 (en) * 2015-12-31 2019-04-03 Huawei Technologies Co., Ltd. Method and system for writing data
EP4221685A1 (en) 2020-09-29 2023-08-09 Oxford University Innovation Limited Stroke treatment
JP2022080126A (ja) * 2020-11-17 2022-05-27 三菱鉛筆株式会社 肥料粒子
PL247686B1 (pl) * 2023-02-21 2025-08-18 Inst Katalizy I Fizykochemii Powierzchni Im Jerzego Habera Polskiej Akademii Nauk Sposób wytwarzania wielordzeniowego nanonośnika polielektrolitowego syntetyzowanego na bazie siarczanu dodecylu sodu i wielordzeniowy nanonośnik polielektrolitowy do zastosowania do leczenia w terapii przeciwnowotworowej
CN116925337B (zh) * 2023-09-19 2023-12-01 广东药科大学 一种多巴胺衍生物的靶向型纳米载体构建的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5569509A (en) * 1979-11-30 1980-05-26 Mcleod Patrick Biologically decomposable particle
FR2504408B1 (fr) * 1981-04-24 1986-02-14 Couvreur Patrick Procede de preparation de particules submicroscopiques, particules ainsi obtenues et compositions pharmaceutiques les contenant
JPS6061521A (ja) * 1983-09-16 1985-04-09 Kyowa Hakko Kogyo Co Ltd マイクロカプセル化製剤
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
JP2930421B2 (ja) * 1994-02-28 1999-08-03 メディノヴァ メディカル コンサルティング ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬剤組成物、その製造方法及びその使用方法
ATE261721T1 (de) * 1997-06-13 2004-04-15 Nanopharm Ag System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
AUPO888097A0 (en) * 1997-08-29 1997-09-25 Biotech Australia Pty Limited Cross-linked particles
EP1010435B1 (en) * 1997-09-05 2010-11-03 Maruho K.K. Nanocapsule preparations for treating intraarticular diseases
FR2775435B1 (fr) * 1998-02-27 2000-05-26 Bioalliance Pharma Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
EP1379227A4 (en) * 2001-03-21 2007-12-12 Univ Kentucky Res Found Microemulsions as precursors to solid nanoparticles
FR2841137B1 (fr) * 2002-06-20 2004-08-13 Bioalliance Pharma Systeme de vectorisation comprenant des nanoparticules de taille homogene d'au moins un polymere et d'au moins un polysaccharide charge positivement
WO2004017945A1 (en) * 2002-07-29 2004-03-04 Nanodel Technologies Gmbh Nanoparticles for dna administration to a target organ

Also Published As

Publication number Publication date
WO2006029845A2 (en) 2006-03-23
EP1796650A2 (en) 2007-06-20
US20070292524A1 (en) 2007-12-20
CN101072553A (zh) 2007-11-14
EP1796650B1 (en) 2009-01-07
WO2006029845A3 (en) 2006-07-20
DK1796650T3 (da) 2009-03-09
ATE419842T1 (de) 2009-01-15
DE602005012289D1 (de) 2009-02-26
ES2318531T3 (es) 2009-05-01
CA2579957A1 (en) 2006-03-23
JP2008513363A (ja) 2008-05-01

Similar Documents

Publication Publication Date Title
WO2006029845A3 (en) Delivery vehicle containing nanoparticles
TWI315203B (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
WO2009135190A3 (en) Therapeutic calcium phosphate particles and methods of making and using same
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
WO2006039704A3 (en) Pharmaceutical composition and method for treating a joint capsule arthropathy
WO2007085629A3 (en) Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents
WO2008046581A3 (de) Substituierte tetrahydropyrrolopyrazin-verbindungen als inhibitoren der monoaminwiederaufnahme und deren verwendung in arzeimitteln
WO2009102467A3 (en) Devices, formulations, and methods for delivery of multiple beneficial agents
WO2005089106A3 (en) Degradable nanoparticles
MX2007010996A (es) Nuevas composiciones de liposomas.
NZ595313A (en) The Use Of Nanoparticles Comprising Rapamycin Or Taxane In The Treatment Of Proliferative Diseases
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
WO2004082628A3 (en) Improved bioavailability and improved delivery of acidic pharmaceutical drugs
WO2006018184A3 (de) Spirocyclische cyclohexan-derivate
WO2007098964A3 (en) Pyrrazole derivatives as sigma receptors antagonists
WO2007093975A3 (es) Uso del factor pedf para inducir la renovación de células
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
WO2006133707A3 (en) Anti-cancer combination treatment and kit-of-part
DE602005027059D1 (de) Polymer-füllstoff-komposite für die kontrollierte abgabe von therapeutischen mitteln aus medizinischen artikeln
GB2446341A (en) Method and system for transdermal drug delivery
WO2010022031A8 (en) Topical hydrogel composition
IL195907A0 (en) Protein-binding methotrexate derivatives, and medicaments containing the same
WO2008051527A3 (en) Sustained release of agents for localized pain management
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen